Caffeic acid-pYEEIE (TFA)-5 mg

Description

Caffeic acid-pYEEIE TFA, a non-phosphopeptide inhibitor, exhibits potent binding affinity for the GST-Lck-SH2 domain[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-immunoregulation–C41H51F3N5O21P—-[1]See-Hyoung Park, et al. Design and characterization of non-phosphopeptide inhibitors for Src family SH2 domains. Bioorg Med Chem Lett. 2002 Oct 7;12(19):2711-4.—-1037.83–98.50–O=C(O)CC[C@@H](C(O)=O)NC([C@H]([C@@H](C)CC)NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CC1=CC=C(OP(O)(O)=O)C=C1)NC(/C=C/C2=CC=C(O)C(O)=C2)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O–Inflammation/Immunology–H2O : 50 mg/mL (ultrasonic)–Src—-Protein Tyrosine Kinase/RTK–Peptides